2 252 878 preferanseaksjer fra forrige emisjon, 10,43mill/8=1 303 750 aksjer i denne emisjonen. Totalt 3,56mill preferanseaksjer x 16,67 x 3?
Mulig du har rett. Min forståelse var at det var levere. Dobbeltsjekker med selskapet
178 mnok er korrekt. Ingen utbetaling på ordinære aksjer før etter det beløpet.
𝐕𝐞𝐫𝐲 𝐢𝐧𝐭𝐞𝐧𝐬𝐞 𝐰𝐞𝐞𝐤 𝐢𝐧 𝐆𝐞𝐫𝐦𝐚𝐧𝐲 𝐯𝐢𝐬𝐢𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚 𝐚𝐧𝐝 𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐧𝐢𝐜𝐚 𝐜𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞𝐬 𝐚𝐧𝐝 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧𝐬!
This week, our CEO, Harald Wahl Breivik, and our CCO, Salvatore Micali, have been attending the MEDICA - Leading International Trade Fair in Düsseldorf (Mon 11 & Tue 12 Nov) and Electronica in Munich (Wed 13 & Thu 14 Nov), meeting numerous partners and customers.
𝐅𝐨𝐜𝐮𝐬 𝐚𝐫𝐞𝐚𝐬: 𝐨𝐫𝐠𝐚𝐧𝐢𝐜, 𝐩𝐫𝐢𝐧𝐭𝐞𝐝, 𝐚𝐧𝐝 𝐟𝐥𝐞𝐱𝐢𝐛𝐥𝐞 𝐞𝐥𝐞𝐜𝐭𝐫𝐨𝐧𝐢𝐜𝐬 𝐟𝐨𝐫 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐰𝐞𝐚𝐫𝐚𝐛𝐥𝐞𝐬, 𝐬𝐦𝐚𝐫𝐭 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞𝐬, 𝐈𝐨𝐓, 𝐝𝐢𝐬𝐩𝐥𝐚𝐲𝐬, 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐚𝐥 𝐚𝐧𝐝 𝐜𝐨𝐧𝐬𝐮𝐦𝐞𝐫 𝐞𝐥𝐞𝐜𝐭𝐫𝐨𝐧𝐢𝐜𝐬.
CondAlign is proud to announce the commercial launch of E-Align25!
Our technology team has been relentlessly working on developing the next generation of anisotropic conductive film, with a pitch of only 25 µm. The final result has the potential to deeply change the electronics industry!
E-Align25 is the only electrically conductive adhesive on the market capable of cold bonding fine electronic devices and components, without the need for high temperature/pressure curing, during or after application.
Compared to other solutions available in the market, E-Align25 has better conductivity performance, reduced carbon footprint, while being cost-efficient and easier to apply.
Typical applications of E-Align25:
· Printed electronics
· Temperature sensitive substrates
· Fine pitch flex cables and connectors
· Fine pitch flexible displays
· Thin electrical laminates
2 Likes
Spennende tider. De er vel i dialog med potensielle kjøpere
Men selvtilliten i sånne situasjoner har fått seg en bra knekk sett i lys av det som har skjedd i andre NTG aksjer i det siste.
Rett og slett helt umulig å vurdere sjansene selv om ledelsen sier de har gode dialoger
| ## CondAlign - Q3-2024 results | ### Company news | ### 2024-11-30 17:29:52 |
|---|---|---|
| Condalign’s traction in the market continues in the third quarter reaching +350 leads and the feedback received continue to be consistently positive, often surpassing that of our competitors. As a result, we also see that we continue to grow the number of customers, and we experience several inbound interest from new markets. There are ongoing discussions regarding high volume RFQ’s that we expect to increase steadily and be materialized late 2024 or/and in 2025. |
In August CondAlign signed a distribution agreement with industry leader Tapecon Inc. to penetrate the North American market. This collaboration marks a significant milestone for CondAlign in the commercialization of its groundbreaking offerings and preparation for its North American market penetration. CondAlign’s E-Align products leverage CondAlign’s proprietary technology, enabling seamless electronic connectivity. Deliveries to Tapecon will commence with pilot series and initial commercial supply in 2024, with projected growth to an annual revenue exceeding NOK 20 million by 2026. This partnership is a testament to CondAlign’s commitment to scaling its innovative technology globally, setting the stage for remarkable growth and industry disruption in the years to come.
On Thermal Interface Materials (TIM) for electric vehicle batteries and electronics applications we continue to see a wider market potential for our products. The TIM market is expected to grow rapidly in the years to come and we see strong interest in the ongoing commercial discussions we have with different parties.
Securing the growing interest with large scale production through a CMO is going according to plan, and large volume production with a European CMO is expected to be signed and kicked off during Q4.
Financially, revenues for the third quarter of 2024 ended at NOK 0.2 million, up from NOK 0.0 million in the same period last year. EBITDA (included capitalized internal development cost) ended at NOK -10.0 million, down from NOK -5.0 million in 2023. In the beginning of the third quarter a private placement (the “Private Placement”) was concluded and the company raised gross proceeds of NOK 37.6 million, including conversion of existing debt of NOK 25.8 million. This funding have secured time for building of customer backlog as well as attracting strategic partners.
As communicated in previously, CondAlign are also in the process of identifying strategic alternatives for the company. The discussions are at an early-phase stage, and there are ongoing discussions on structure, which may involve a sale of assets or shares in CondAlign. No guarantees can be given at this stage as to whether any of these discussions may materialize or the timing of any transaction.|
Produktene ser bra ut…hadde vært fint med noen ordrer nå ….
Nå som CrayoNano har gått i vifta får vi håpe CondAlign har bedre kontroll. De er vel i en prosess, men det er ikke altfor lenge til pengene er brukt opp her heller…
Har ikke mye trua nå
Alt NTG er involvert i går at skogen virker det som
Er vel ikke lang runway de har igjen mtp på siste investerings runden… ut februar ble vel nevnt om jeg ikke husker feil… får håpe det blir solgt snart eller at det kommer inn en tyngre industriell investor.
Lurer på om Tapecon har skapt noe business for dem.
https://www.bizjournals.com/buffalo/news/2024/09/06/buffalo-tapecon-exclusive-norway-condalign.html
Vel vel… er ikke lenge til alt blir avklart. Vi får se.
Litt bekymret for hva som skjer hvis de pågående samtalene ikke fører frem. Da er det tomt for penger og man er i samme situasjon som CrayoNano.
Så forøvrig det var flere som spurte hvor man kunne få tak i prøver når de lanserte E-align25 på LinkedIn, så det kan jo tyde på at produktet er etterspurt.
https://newsweb.oslobors.no/message/638067
CondAlign – Company update and potential capital raise
CondAlign experience strong traction in the market for its high-value and unique products. A significant number of well-known international companies are in the mid of or have finalized the design-in process with CondAlign’s products. As a result of this CondAlign have received several requests for proposal for high volume delivery, and the number of requests are expected to grow strongly going forward.
As previously communicated, the Company and its board are in the process of identifying strategic alternatives for the Company. These processes are progressing well, and it may involve a sale of assets or shares in CondAlign. While the market traction is strong and the strategic discussions are positive, the Company needs to secure funding to finance the current business and these strategic discussions.
With this background the Company has resolved to explore a potential capital raise through the issuance of a convertible loan to raise gross proceeds of minimum NOK 9 million and maximum NOK 15 million. If the minimum proceeds are raised the Company expects the current cash runway to be extended to May 2025, which is expected to give ample time to continue but not necessarily conclude the ongoing strategic process.
The application period for the convertible loan is expected to commence on 10 February 2025 at 09:00 (CET) and last until 17:00 (CET) on 17 February 2025 (subject to extension). The convertible loan will only be directed at existing shareholders and certain other investors in reliance on applicable prospectus exemptions.
The convertible loan can be converted into units of shares in the existing share classes of preference shares and ordinary shares at a conversion price of NOK 8 per unit. Each unit includes 1 preference share and 50 ordinary shares.
The convertible loan will be contingent upon approval by an extraordinary general meeting of the Company. The Company will revert with further information about the convertible loan after expiry of the application period.
For more information, please contact:
Rune Rinnan
Group CEO
Chair CondAlign AS
Tel: +47 900 56 028
Harald Wahl Breivik
CEO CondAlign AS
Tel: +47 976 33 815
harald.breivik@condalign.no
Rune Rinnan ftw 
1 Like
Kan jo nesten kjøre copy paste i fra meldingene til Crayonano 
Fatter ikke at de frister med sånne tilbud for å få inn noen få kroner. Det lyktes jo ikke i crayonano, og nå er det mye verre. En preferanseaksje samt 50 normale aksjer. De eksisterende aksjene er jo null verdt. 🤷
Eller er det sånn at condalign virkelig har en potensiell kjøper, og Rinnan prøver å grafse til seg mest mulig av kaken…
Da er vi oppe i salgsverdi på over 235-273 mill før vanlige aksjer får noe. Har man ikke trua på det spiller jo de 50 vanlige aksjene liten rolle…
Skulle ønske de annonserte design-in og verdi på ordre.
Noen som tenker å bli med her eller har alle gitt opp?
Vurderer. Hadde vært greit med noe nøktern info og edruelig løyperapport.